Lobe Sciences Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LOBEF research report →
Price Chart
About the company
Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD).
- CEO
- Frederick Dominick Sancilio
- IPO
- 2023
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on LOBEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $15.88M
- P/E
- -3.88
- PEG
- -0.09
- P/S
- 0.00
- P/B
- 11.78
- EV/EBITDA
- -3.13
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -338.76%
- ROIC
- -193.66%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $0-100.0%
- Op Income
- $-4,176,322
- Net Income
- $-4,424,660-0.1%
- EPS
- $-0.03+11.9%
- OCF Growth
- -116.3%
- FCF Growth
- -116.3%
- 52W High
- $0.06
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.28
- RSI (14)
- 49
- Avg Volume
- 45.19K
No earnings-call transcripts are available for LOBEF yet.
- Free Float
- 27.0%
- Shares Outstanding
- 284.10M
- Float Shares
- 76.59M
Our LOBEF coverage
Recent articles, reports, and earnings notes.
No research on LOBEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LOBEF report →Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement
accessnewswire.com · Aug 20
Lobe Sciences Reports Third Quarter 2026 Financial Results
accessnewswire.com · Aug 18
Lobe Sciences Ltd. Announces Non-Brokered Private Placement
accessnewswire.com · Aug 12
Lobe Sciences Announces Results of Annual General and Special Meeting of Shareholders
accessnewswire.com · Aug 5
Lobe Sciences Files Management Information Circular for Annual General and Special Meeting on July 30, 2026
accessnewswire.com · Jul 7
Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares
accessnewswire.com · Jun 9
Lobe Sciences Announces Proposed Shares for Debt Transaction
accessnewswire.com · Jun 1
Lobe Sciences Ltd. Announces Participation in the D.
accessnewswire.com · May 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.